Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The HMGCR gene encodes HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway for cholesterol biosynthesis. While widely studied for statin targets in cardiovascular disease, HMGCR activity and cholesterol metabolism in the brain are directly relevant to Alzheimer's disease pathogenesis. Brain cholesterol homeostasis is critical for neuronal function, synaptic plasticity, and amyloid processing.
| HMGCR | |
|---|---|
| Full Name | 3-Hydroxy-3-Methylglutaryl-CoA Reductase |
| Chromosome | 5 |
| Location | 5q13.3 |
| NCBI Gene ID | 3155 |
| OMIM | 142745 |
| Ensembl ID | ENSG00000013113 |
| UniProt ID | P04035 |
HMGCR plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer's disease pathogenesis through multiple mechanisms:
The brain contains approximately 25% of the body's cholesterol but is isolated from peripheral cholesterol by the blood-brain barrier. Key mechanisms include:
| Mechanism | Effect |
|---|---|
| Altered cholesterol metabolism | Increases Aβ production |
| Dysregulated APP processing | Enhances amyloidogenesis |
| Impaired synaptic cholesterol | Defects in neurotransmission |
| Oxidative stress | Neuronal vulnerability |
| Disease | Relationship |
|---|---|
| Hypercholesterolemia | Primary association |
| Alzheimer's Disease | Secondary complication |
| Cardiovascular Disease | Comorbidity |
HMGCR inhibitors (statins) have been studied extensively in AD:
The HMGCR gene shows distinct expression patterns:
Bjorkhem I, et al. (2006). "Cholesterol 24-hydroxylase: an enzyme of cholesterol elimination in the brain." Biochemical and Biophysical Research Communications. DOI:10.1016/j.bbrc.2006.02.114
Carter CJ. (2007). "Alzheimer's disease: APP, gamma-secretase, APOE, LDLR, and cholesterol: a pathological triad?" Journal of Neurochemistry. DOI:10.1111/j.1471-4159.2007.04586.x
Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Hmgcr — 3 Hydroxy 3 Methylglutaryl Coa Reductase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.